Insurance Formularies Holding Up Lower-Emission Asthma, COPD Inhalers

(MedPage Today) -- Commercial insurance formularies have posed a barrier to cutting greenhouse gas emissions from metered-dose inhalers used to treat asthma and chronic obstructive pulmonary disease (COPD), a study showed. Lower-emission versions...